Grifols, from Spain

Business: Chemistry, Pharmaceutical, Manufactures, Healthcare,

Auditor: KPMG.

Last Balances States (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Total Assets 7,276.096 5,846.159 24.46
Total Liabilities
5,038.472
3,901.399 29.15
Equity
2,237.624
1,944.760 15.06
Working Capital
1,615.413
1,296.902 24.56
May 15, 2017

Basic Stock Information

Last Quote (EUR)
25.480
PER
25.61
Capitalization (Mns of EUR)
8,579.268
Capitalization/Equity
3.8341
Last month variation (%)
7.511
Last 3 months variation (%)
22.031
Last 6 months variation (%)
37.991
Last 12 months variation (%)
40.193

Last Financial Statement (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Revenue
1,610.780
1,380.841 16.65
EBIT
417.334
380.363 9.72
Net Profit
222.971
180.435 23.57
ROCE (%) 6.441 7.453 -13.58
ROE 0.100 0.093 7.53
ROA 0.031 0.031 0.0
Net Profit over revenue 0.138 0.131 5.34
EBIT over revenue 0.259 0.275 -5.82
EBITDA over revenue 0.315 0.324 -2.78
Assets Rotation 0.221 0.236 -6.36
Earning per share (EUR) 0.64859 0.52486 23.57

Stock-Market Evolution

Key Figures (EUR)

Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
H1 1,610.780 507.523 417.334 289.573 222.971 0.138 0.259 0.100 0.031 1,615.413 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 2,741.732 868.045 736.120 497.536 342.054 0.125 0.268 0.162 0.059 1,424.364 Details
H2 1,360.891 420.333 355.757 237.258 161.619 0.119 0.261 0.077 0.028 1,424.364 Details
H1 1,380.841 447.712 380.363 260.278 180.435 0.131 0.275 0.093 0.031 1,296.902 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 2,620.944 802.135 660.084 387.948 255.377 0.097 0.252 0.136 0.045 1,341.699 Details
H2 1,304.239 399.605 321.189 183.591 121.927 0.093 0.246 0.065 0.022 1,341.699 Details
H1 1,316.705 402.530 338.895 204.357 133.450 0.101 0.257 0.073 0.023 1,218.882 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 1,795.613 404.149 278.861 80.023 50.228 0.028 0.155 0.030 0.009 1,283.138 Details
H2 1,160.272 285.704 210.132 54.063 31.615 0.027 0.181 0.019 0.005 1,283.138 Details
H1 635.341 118.445 68.729 25.960 18.613 0.029 0.108 0.012 0.003 1,146.736 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 990.730 255.103 209.683 157.784 115.267 0.116 0.212 0.163 0.061 720.956 Details
H2 502.921 108.780 83.563 68.932 49.437 0.098 0.166 0.070 0.026 720.956 Details
H1 487.809 146.323 126.120 88.852 65.830 0.135 0.259 0.095 0.034 768.335 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 913.186 266.041 226.528 203.994 147.570 0.162 0.248 0.255 0.089 705.535 Details
H2 442.655 125.991 104.896 88.986 65.422 0.148 0.237 0.113 0.039 705.535 Details
H1 470.531 140.050 121.632 115.008 82.148 0.175 0.258 0.163 0.060 369.284 Details

Additional information

  • Capitalization: Total number of shares x (1 - Treasury shares) x Last Quote = (343777454) x (1 - 0.02057 ) x (25.480 EUR) = 8579.268 Mns of EUR
  • PER: Last Quote (25.480 EUR) / Last annual earning per share (0.99499) = 25.608

News